Women laughing together at an exercise class.
Research shows exercise is beneficial at every age and fitness level Apr 18, 2019

A comprehensive review of existing research has found that any amount of exercise is good, but working out in different ways throughout the week is the best prescription for optimal cognitive and body function. The study, published recently in the journal Neurobiology of Aging, also found a relationship between improved physical health and improved overall brain health. Regular aerobic and resistance training also reduces frailty and its associated hazards in older adults.

Parents walking with child.
Common treatment for multiple sclerosis may prolong life Mar 18, 2019

A new study from Dr. Elaine Kingwell and Dr. Helen Tremlett reveals that a widely prescribed drug for multiple sclerosis (MS) is associated with longer survival for patients. 

Dr. Helen Tremlett at the Djavad Mowafaghian Centre for Brain Health.
Disability progression in multiple sclerosis linked to income, education Feb 22, 2019

Neighbourhood income and education level is associated with risk of disability progression in patients with multiple sclerosis, suggests new research from Dr. Helen Tremlett and colleagues at the University of British Columbia.

Young people in New York City.
Trio of papers offers new data on MS prevalence in the US Feb 15, 2019

More than 90,000 Canadians live with multiple sclerosis (MS) a chronic disease affecting the brain and central nervous system. It often affects young adults, with diagnosis generally occurring between 25 and 45 years of age. For those seeking to understand how MS affects individuals and populations, Canadian health data offers a wealth of information for researchers, with findings of relevance to all Canadians. Epidemiological data captured across Canada has, for many years, informed research and care across the country and, sometimes, in the United States (US).

Dr. Judy Illes outside the Djavad Mowafaghian Centre for Brain Health.
Neuroethics to form foundation of multi-pillar Canadian Brain Research Strategy Feb 6, 2019

“The world is mobilizing around a strategic approach to brain research,” says Dr. Judy Illes, “and neuroethics is an anchor point.”

While leaders in brain research around the world have been building toward an international brain research strategy, Canada has been working on a complementary approach that accelerates international efforts but leverages the unique advantages of Canadian researchers and Canada as a neuroscience-driven nation.

Dr. Jacqueline Quandt outside of the Djavad Mowafaghian Centre for Brain Health.
Protein switch identified in connection with disability progression in MS Jan 8, 2019

Pictured: Dr. Jacqueline Quandt. Image credit: Paul Joseph/UBC.

Alireza Kamyabi and colleagues in the MacVicar lab.
Member news: December 2018 Dec 20, 2018

Pictured: Alireza Kamyabi (smiling, centre), graduate student in Dr. Brian MacVicar's lab, and colleagues present their research during a recent donor tour. Image credit: Paul Joseph/UBC.

Dr. Shannon Kolind (left) and Dr. Karen Lee (right).
CanProCo study unites Canadian MS researchers in a longitudinal, next-generation research initiative Dec 11, 2018

Pictured: Dr. Shannon Kolind (left) and Dr. Karen Lee (right), taken at the Djavad Mowafaghian Centre for Brain Health on December 10, 2018. Image credit: UBC Faculty of Pharmaceutical Sciences/Justin Ohata.

Venogram image of the brain.
Tissue orientation causes bias in MRI measurements of brain blood flow Nov 21, 2018

Pictured: a venogram showing blood vessels in the brain.

New research by Dr. Alex Rauscher, an MRI physicist and Canada Research Chair in Developmental Neuroimaging, has shown that about half the blood vessels in the brain's white matter run in parallel with nerve fibres.

Dr. Anthony Traboulsee consults a patient in the UBC Hospital MS Clinic.
Clinical trial results put liberation therapy controversy to rest Oct 30, 2018

For Dr. Anthony Traboulsee (pictured above), Director of the UBC MS & NMO Research Program at the Djavad Mowafaghian Centre for Brain Health and lead investigator on two Canada-wide clinical trials to determine the efficacy of liberation therapy in MS, it was an opportunity to listen to the community.